FeesSafety
Pluang+

Medtronic reports Q3 earnings after MiniMed spin-off, expects revenue growth but margin pressure.

Company Fundamentals
22 Nov 2026, 02:07 WIB
Leo Sun
View Source
Neutral
Medtronic reports Q3 earnings after MiniMed spin-off, expects revenue growth but margin pressure.

Medtronic will release its Q3 fiscal 2027 earnings on Nov. 24, marking its first report after spinning off its diabetes unit, MiniMed, in October. The company expects a 6% revenue increase year-over-year but a 2% dip in adjusted earnings per share due to margin pressures from reinvestments and acquisitions. Despite challenges like supply chain issues and competition, Medtronic's revenue grew 5.8% in fiscal 2026 and is forecasted to rise 7.25%-7.75% in fiscal 2027. Investors are advised to watch for organic growth and margin management before considering it a stable dividend stock.

Medtronic PLC (MDT) trades at USD 99.94 with a slight 0.67% decline as of Nov 22, 2026 03:01 WIB on Pluang, reflecting cautious investor sentiment ahead of its Q3 fiscal 2027 earnings report. MiniMed Group Inc. (MMED), recently spun off, is priced at USD 16.01, down 1.54% on the same date. The dividend yield for Medtronic stands at 2.88%, highlighting its appeal despite expected margin pressures and reinvestment challenges noted in the upcoming earnings.

More News (MDT)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App